Cardiff Oncology (FRA:XE7C) Current Deferred Taxes Liabilities : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Cardiff Oncology's current deferred tax liabilities for the quarter that ended in Sep. 2024 was €0.00 Mil.

Cardiff Oncology Current Deferred Taxes Liabilities Historical Data

The historical data trend for Cardiff Oncology's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Current Deferred Taxes Liabilities Chart

Cardiff Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Cardiff Oncology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cardiff Oncology Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiff Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

CRDF:USA

Address

11055 Flintkote Avenue, San Diego, CA, USA, 92121

Website

https://www.cardiffoncology.com

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

Cardiff Oncology Headlines

No Headlines